New & Insights — Page 27 of 27 — Updates & Announcements — Omega Funds

LinkedIn Email

888 Boylston Street, Suite 1111, Boston, MA 02199
Place du Molard 7, 1204 Geneva, Switzerland

All Rights Reserved. Omega Fund Management, LLC 2026

Site by Show + Tell

Updates &
Announcements

View all press

October 15, 2025

Omega Position Paper: AI in Drug Development and Discovery

Omega Position Paper: AI in Drug Development and Discovery

March 4, 2024

Omega Insights Series: The GLP-1 Revolution

Omega Insights Series: The GLP-1 Revolution

December 7, 2023

Omega Insights Series: Drug Pricing, Inflation Reduction Act and US Politics – Potential Impact on Biopharma Overview

Omega Insights Series: Drug Pricing, Inflation Reduction Act and US Politics – Potential Impact on Biopharma Overview

September 7, 2023

Omega Insights Series: AI in Drug Discovery and Development

Omega Insights Series: AI in Drug Discovery and Development

Omega Funds

4 Jan 2019

Sana Biotechnology Launches Focusing on Engineering Cells to Create a New Class of Medicines

Sana Biotechnology

Sana Biotechnology Launches Focusing on Engineering Cells to Create a New Class of Medicines

Omega Funds

4 Jan 2019

Ready to launch: A record 59 NME approvals in 2018 means investors will focus on launces in 2019 – BioCentury

BioCentury

Ready to launch: A record 59 NME approvals in 2018 means investors will focus on launces in 2019 – BioCentury

Omega Funds

19 Jul 2016

MIT Enterprise Forum | Medtech Fireside Chat

MIT Enterprise Forum | Medtech Fireside Chat